Question follow-through · 543
Cancer: Clinical Trials
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of trends in the proportion of Phase II and Phrase III in commercial oncology clinical trials.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 13 May 2026
- Target answer date
- 18 May 2026
- Answer
- 22 May 2026 · 9 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Palliative Care · 21 May 2026
- Pathology: Consultants · 25 Jun 2026
- Food: Nutrition · 6 Jul 2026
- Hospices · 8 Jul 2026
- Crohn's Disease and Ulcerative Colitis · 28 Aug 2026
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
13 May 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of trends in the proportion of Phase II and Phrase III in commercial oncology clinical trials.
18 May 2026
Target answer date
Date supplied by the official written-questions record.
22 May 2026
Answer published
The Department holds data on commercial clinical trials by phase and therapeutic area, including oncology. However, we do not routinely assess trends in specific segments such as Phase II and Phase III oncology clinical trials.We use this information alon...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Palliative Care
21 May 2026 · To ask the Secretary of State for Health and Social Care, for an update on the progress of the Palliative and End of Life Care Modern Service Framework.
Pathology: Consultants
25 Jun 2026 · To ask the Secretary of State for Health and Social Care, what steps he plans to take to improve the level of consultant staffing in pathology departments to meed the target of 98% of histopathology tests to be reported within 10 days by March 2029, as sp
Food: Nutrition
6 Jul 2026 · To ask the Secretary of State for Health and Social Care, if he will take steps to use the Healthy Food Standard to help ensure that supermarkets provide a range of affordable, healthy products in smaller convenience stores.
Hospices
8 Jul 2026 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support the hospice sector.
Crohn's Disease and Ulcerative Colitis
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what data her Department holds on the number and proportion of people with Crohn’s Disease or Ulcerative Colitis diagnosed following an A&E attendance, emergency hospital admission, or emergency su
Inflammatory Bowel Disease
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what assessment she has made of the potential impact of a delayed diagnosis of Inflammatory Bowel Disease on A&E capacity over the past 12 months.
Cancer: Drugs
28 Aug 2026 · To ask the Secretary of State for Health and Social Care, what steps the Government is taking to support Enhertu being made available in England.
Breast Cancer: Research
2 Sept 2026 · To ask the Secretary of State for Health and Social Care, whether she will set out a timeline for the delivery of funding for the Lobular Moonshot Project.